Owing to the importance of interleukin (IL)-12 in regulating immune responses, we have determined the complete genomic sequence and organization of the gene encoding its p40 subunit. The genomic sequence was determined and was compared to cDNA sequences to derive exon/intron boundaries. Unusually, both the first and last of the eight exons of this gene are not translated. An extensive search identified several polymorphisms in IL-12p40, including repeat elements in introns 2 and 4 and a polymorphic TaqI site in the 3ЈUTR. However, no polymorphisms were found which could result in amino acid substitutions. This finding places constraints on any preferential involvement of alleles of IL-12p40 in contributing to autoimmune, inflammatory or infectious diseases. Genes and Immunity (2000) 1, 515-520.
The immune response is regulated by the interaction of lymphocytes with antigen-presenting cells, and the cytokines released by each of these cell types. One of the most interesting is interleukin-12 (IL-12), a proinflammatory cytokine (see Trinchieri 1 for review). It can mediate a number of different activities, including stimulation of interferon-gamma secretion from resting lymphocytes, NK cell stimulation and cytolytic T cell maturation. Perhaps most crucially, IL-12 also affects the progression of uncommitted T cells to either the Th1 lineage, which in general is characterised by secretion of lymphokines associated with cell-mediated, rather than humoral, immunity 1 . IL-12 is an unusual cytokine in that it is composed of two disulphide-bonded polypeptide chains of 35 and 40 kD. The 35 kD chain has homology with IL6, 2 and the p40 chain has homology with one of the interleukin receptor chains, IL6R. 3 In addition to forming heterodimers with p35, the p40 subunit may also form homodimers. These p40 homodimers are capable of competing with the p35-p40 heterodimers and so may modulate IL-12 function. 4 While many cell types express the p35 chain, the p40 subunit is expressed principally by activated macrophages and B cells, and its expression may be upregulated by interferon gamma.
Given the importance of the IL-12 p40 subunit in the immune system, it is possible that genetic variants in the gene encoding this cytokine may be important in causing immunoregulatory abnormalities. In this respect, deficiencies in production of the IL-12 receptor cause severe infections in humans. 5 While we anticipate that IL-12-deficient individuals would be found very rarely, less drastic changes in the genes encoding the IL-12 subunits could interact with other polymorphisms to predispose to susceptibility or resistance to infectious diseases or to autoimmunity. In anticipation of this possibility, we undertook to determine the complete nucleotide sequence of this gene and its flanking sequences, to define polymorphisms associated with it, and to position it accurately on the genetic map of chromosome 5q.
High resolution mapping
Although IL-12p40 had been mapped to chromosome 5q31-33, 6 its position relative to microsatellite markers used in genetic studies has not been reported. Therefore, to localize IL-12p40 relative to other genes (eg GABRA1 7 and GABRA6 8 ) and genetic markers D5S403, D5S10 and D5S4121 9 in this region, we used radiation hybrid mapping. 10 Comparison with previously mapped markers confirmed the assignment of IL-12p40 to distal chromosome 5q (Figure 1a) . The optimal location for this gene was 3.3 centiRays (cR) telomeric from the microsatellite marker D5S412, and 3 cR centromeric from the anonymous DNA sequence, WI-9929 and a further 2.2 cR from D5S403 ( Figure 1a) . These results integrating the genetic 9 and physical maps of distal chromosome 5q will be useful for further genetic studies examining potential roles for IL-12p40 in disease. An inspection of the map of distal human chromosome 5 does not reveal any known 7 and GABRA61 8 and microsatellite markers. 9 Oligonucleotides were designed to amplify sequences from the 3Ј untranslated region of the human IL-12p40 gene but not from hamster genomic DNA. Radiation hybrids from the Genebridge 4 series (Research Genetics, AL, USA) was tested for human IL-12p40. Additional primers, including GABRA1A 7 and D5S403, D5S410 and D5S412. 9 were also tested. The results were used to search against the Whitehead Institute database (http://www-genome.wi.mit.edu/cgibin/contig/rhmapper.pl) using a LOD = 15 for linkage to the framework map. (b) Detailed restriction maps of the PAC and BAC clones containing IL-12p40. A PAC containing IL12p40 was isolated by screening pools from the human PAC library produced by Ioannou et al.
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The direction of transcription of the gene is shown by the arrow. The marker 93/SP6 was obtained from the end sequence of PAC93-1, and used to screen a BAC library. The resulting clone, BAC 626-I9, had an 165 kb insert containing the entire PAC93-1 insert (130 kb) with an additional 2.5-and 30-kb at its SP6 and T7 ends, respectively. Restriction enzyme maps were prepared after digestion with NotI, SalI, SacII and MluI, followed by resolution by pulsed field gel electrophoresis, and hybridization with oligonucleotides complementary to the vector ends (T7 or SP6) or to the promoter or 3ЈUTR of IL-12p40. (c) Genomic organisation of the human IL-12p40 gene. By comparing the complete genomic sequence with published cDNA sequences, the position of exons 1-8 and introns was deduced. Open boxes = coding exons; first and last exons are non-coding. Size of introns is indicated below the line. Start and stop codons are indicated. The asterisk indicates the presence of a mRNA degradation motif. 17 Arrows indicate approximate positions of confirmed polymorphisms (see Tables 2, 3 and 4) . diseases mapping to this region which could be attributable to variants in IL-12p40.
A phage P1-derived artificial chromosome (PAC) clone was isolated from the human PAC library produced by Ioannou et al 11 with primers designed to amplify a segment from the 3Ј untranslated region of IL-12p40. The PAC clone 93-1 had an insert size of 130 kb. The sequence from the SP6 end of this clone was used to design primers to isolate an overlapping clone from a bacterial artificial chromosome (BAC) library. 12 A high resolution map of these clones is shown in Figure 1b . Characterisation of these clones showed that they both contained the complete gene which also was arranged 3Ј→5Ј with respect to the centromere. The MluI site within the IL-12p40 promoter was located 90 kb from the SP6 end of the PAC clone (Figure 1b) .
Determination of IL-12p40 genomic sequence
Only part of the promoter and the exon 1 genomic sequences of human IL-12p40 have been determined previously. 13 In order to complete the sequence of the human IL-12p40 gene, we used the PAC clone, 93-1, as a template. DNA sequencing was performed using a walking strategy with fluorochrome-labeled dideoxynucleotide terminators, followed by automated analysis. This strategy was used because the priming oligonucleotides could also be used to generate PCR products for polymorphism testing.
A total of over 18 kb of sequence was determined and is deposited with Genbank. By alignment of this genomic sequence with the previously published cDNA 
The complete IL12p40 genomic sequence was determined using PAC 93.1 as a template. The sequence has been deposited in Genbank with accession number AY008847. Exon-intron boundaries were determined by comparison with published cDNA sequences. 2, 14 Exon sequences are shown in bold; splice donor and acceptor sites are single underlined. The start and stop codons (double underlined) are the first and last codons in exons 2 and 7 respectively. Sizes of introns are indicated in Figure 1c. sequences, 2,14 the exact location and sequences of the exons were defined. Sequences at the exon-intron boundaries are reported in Table 1 . The organization of the IL12p40 gene is shown schematically in Figure 1c . An unusual feature of the gene is that it has untranslated exons at both its 5Ј and 3Ј ends. Translation from its corresponding mRNA would be initiated at the first codon in exon 2 and would terminate at the last codon of exon 7.
Comparison of genomic and cDNA sequences
Sequence differences were observed between the sequence of the PAC clone that we determined and the previously reported IL-12p40 sequences, as shown in Table 2 . These sequence differences could either represent genetic polymorphisms or arise from sequencing errors. In order to test whether the differences between 
Creates a TaqI site HUMNKSFP40 TTGTATAGTTCGATGCTAAATGCT L26 same; TaqI+
The IL12p40 genomic sequence summarised in Figure 1c was compared with the previously published sequences of the promoter (HSU89323 13 ) and cDNAs(HUMCLMF40 2 and HUMNKSFP40 14 ) . Differences between these sequences are shown. These differences may affect amino acid substitutions or restriction enzyme (RE) recognition sequences as noted. Differences were confirmed by sequencing of independently derived DNA samples. L3 and L26 are DNA samples derived from anonymous donors homozygous for the 3ЈUTR TaqI− and TaqI+ alleles, respectively.
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the PAC sequence and the cDNA sequences were representative of alleles of the IL-12p40 gene, primers were designed to amplify the relevant regions of the gene from genomic DNA of different individuals (anonymous donors of European descent). PCR products were tested for the presence of genetic variants by either restriction enzyme digestion (where appropriate) or by direct sequencing. In this way, the A→C change in the 3ЈUTR, resulting in creation of a TaqI site, was defined as a true genetic variant. In contrast, the C→G change resulting in the K→N amino acid substitution (exemplified by sequence HUMNKSFP40 14 ) could not be found in DNA representing 224 chromosomes, including 97 which had the same IL-12p40 allele as HUMNKSFP40, as defined by the presence of the 3ЈUTR TaqI (not shown). Similarly, we could not confirm either the exon 7 difference or the promoter differences between the PAC and the published sequences.
Further search for polymorphisms in the IL-12p40 gene
Although no differences in coding sequence could be found between PAC 93-1 and the two published cDNAs, it was of interest to determine whether there were further allelic markers of this gene. We therefore tested DNA from different individuals representative of the TaqI− and TaqI+ alleles for further differences in and around the IL-12p40 gene. Polymorphisms were sought by PCR amplification followed by single strand conformation polymorphism (SSCP), restriction enzyme digestion or direct sequencing. Variants found by SSCP were confirmed by subsequent sequencing (or other methods as appropriate) of samples from a number of unrelated individuals. The results are summarized in Tables 3 and 4 . Our major interest was in finding whether commonly occurring IL-12p40 polymorphisms exist as these may be useful for testing in various disease situations. It should be noted that the possibility of other, rarer, IL12p40 variants was not tested and is not excluded.
Despite our extensive searching, no coding region sequence differences were found. Simple sequence repeat Table 5 Polymorphisms in the IL12p40 gene were sought. DNA fragments covering the entire gene were amplified from a panel of up to 27 unrelated donors and SSCP was performed as follows. Forward and reverse primers shown were selected from the PAC sequence, and used to amplify specific segments of the IL-12p40 gene. 'Standard' PCR conditions were performed incorporating 32 P-dATP: 2Ј at 95°C followed by 35 cycles of 20 s at 95°C, 20 s at 55°C, and 30 s at 72°C; different extension times are indicated. For SSCP, a portion (1 l) of the reaction mix was added to 5 l of loading buffer (95% formamide, 20 mm EDTA, 0.1% NaOH, 0.05% bromophenol blue and 0.15% xylene cyanol) heated at 90°C for 1 min and loaded onto a 4 to 5% polyacrylamide gel (1:45 or 1:90 ratio of N,NЈ-methylene bisacrylamide to acrylamide). The intron 7 product was digested with EcoRV and HindIII prior to SSCP. Electrophoresis was performed at 6W, overnight at room temperature. The gel was blotted on filter paper and exposed to autoradiography overnight at −70°C. Fragments which gave variable size products were selected for sequencing. Note: the sequencing panel was selected so as to be enriched for individuals homozygous for the exon 8 TaqI allele. The number of individuals sequenced who were homozygous for the canonical PAC sequence, or for the alternate non-PAC sequence, are shown, as is the number of heterozygotes.
polymorphisms were discovered in introns 2 and 4. However, these had limited heterogeneity, with only two and three alleles found for each, respectively. A number of apparent single nucleotide substitutions were found. All the polymorphisms listed in Tables 3 and 4 were confirmed by sequencing. Some polymorphisms were examined further in a large sample of unrelated individuals of diverse European descent (Table 5 ). In particular, the 3ЈUTR alleles were found to be in Hardy-Weinberg equilibrium, with the TaqI− allele having a frequency of 0.82. Since this manuscript was in preparation, another group also found the 3ЈUTR TaqI polymorphism by comparing cDNA sequences; 15 they reported the frequency of the TaqI− allele as 0.8, which is similar to the frequency we observed. The TA repeat polymorphism in intron 4 showed a similar distribution, also in Hardy-Weinberg equilibrium. The longest allele of this polymorphism is probably in linkage disequilibrium with the 3ЈUTR TaqI+ allele. Even though the sample size was small, there was a suggestion that other polymorphisms may not be in linkage disequilibrium, notably the two single base changes, each A→G, within 14 bp in intron 2 (Tables 3,  4 ). In sequencing this region from eight individuals, two 
Sequences are shown of polymorphisms between the PAC sequence and PCR products from a donor (L26) homozygous for IL12p40 3ЈUTR TaqI alleles. Genetic variants were detected and confirmed by sequencing of products from other donors as described in Table 3 . Position indicated is the position of the PAC sequence. The number of alleles observed for the repeat polymorphisms is indicated. Allele frequencies were determined by genotyping unrelated subjects of diverse European descent. The intron 4 TA repeat polymorphism was detected on denaturing bis-acrylamide gels. The exon 8 TaqI allele was detected as follows: 2 l of products digested with 1 unit of TaqI in a 10 l reaction volume and incubate at 65°C for 2 h. The number of individuals with each genotype did not differ from that expected if the alleles were in Hardy-Weinberg equilibrium.
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were heterozygous for either form, while of the homozygotes, five had the AA haplotype and one each the AG and GG haplotypes.
There was clustering of the DNA sequence variations. Of the 12 polymorphisms found, four were in intron 1, three were in intron 2, and two in intron 4. The changes in introns 1 and 2 appeared in pairs separated by no more than 60 bp. No polymorphisms were found (by SSCP analysis) in introns 5 and 6. In searching for genetic variants in IL-12p40, no changes were found which would give rise to amino acid changes. An apparent amino acid substitution in comparison with a previously described cDNA sequence could not be found in testing an additional 128 chromosomes. The dearth of any coding sequence changes indicates a high level of conservation between the human subjects tested. Perhaps it was not surprising that no sequence variants were found that resulted in amino acid substitutions, given that IL-12p40 plays a fundamental role in immune regulation. 1 However, this contrasts with the mouse IL-12p40 gene, in which we have defined three alleles encompassing two amino acid substitutions (Ymer et al, submitted) . It also contrasts with the large number of differences displayed between species: there are 116 differences in amino acid sequences between the approximately 335 residues of the mouse and human IL-12p40 proteins. 2, 14, 16 Despite the sequence differences, the genomic organization of mouse 14 and human IL-12p40 genes is similar: both have eight exons and the relative size of the introns is similar in both species. The mouse gene has an untranslated first exon but, unlike the human gene, the last exon does encode part of the final protein product. 14 The polymorphisms we have described will be useful in genetic studies to determine the role of IL-12p40 in regulation of the immune response in health and disease. In view of the absence of common polymorphisms at the level of the human IL-12p40 protein, any future studies of involvement of IL-12p40 variants in disease must contemplate changes in the regulation or expression of the genes. Subtle differences in levels of gene expression or in cell-or stimulus-specific responses may have profound final effects given the capacity of IL-12 to have multiple downstream effects on immune responses.
